Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor

Inflammation, Adenoma and Cancer: Objective Classification of Colon Biopsy Specimens with Gene Expression Signature

(2013) Orsolya Galamb et al.   DISEASE MARKERS

The Cyclooxygenase-2 Inhibitor Etoricoxib Is a Potent Chemopreventive Agent of Colon Carcinogenesis in the Rat Model

(2012) Manpreet Kaur Saini et al.   JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY

A COX-2 inhibitor nimesulide analog selectively induces apoptosis in Her2 overexpressing breast cancer cells via cytochrome c dependent mechanisms

(2009) Bin Chen et al.   BIOCHEMICAL PHARMACOLOGY

Cyclooxygenase-2 Inhibitors Down-regulate Osteopontin and Nr4a2—New Therapeutic Targets for Colorectal Cancers

(2009) Rachid Zagani et al.   GASTROENTEROLOGY

NS-398, ibuprofen, and cyclooxygenase-2 RNA interference produce significantly different gene expression profiles in prostate cancer cells

(2009) M. John-Aryankalayil et al.   MOLECULAR CANCER THERAPEUTICS

Diagnostic mRNA Expression Patterns of Inflamed, Benign, and Malignant Colorectal Biopsy Specimen and their Correlation with Peripheral Blood Results

(2008) O. Galamb et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Cyclooxygenase-2 Inhibition Prevents Migration of Colorectal Cancer Cells to Extracellular Matrix by Down-Regulation of Matrix Metalloproteinase-2 Expression

(2008) Edmund Leung et al.   DISEASES OF THE COLON & RECTUM